CLEO Diagnostics Ltd (COV) Share Price & Analysis

COV Stock Chart & Stats

A$0.30-A$0.01(-1.67%)

At close: Oct 30 4:00 PM GMT+11

Day’s Range: AUD 0.30 - AUD 0.30
52-Week Range: AUD 0.27 - AUD 0.90
Previous Close: AUD 0.30
Volume: 276
Average Volume (3M): 131.31K
Market Cap: AUD 42.00M
Enterprise Value: AUD 62.33M
Total Cash (Recent Filing): N/A
Total Debt (Recent Filing): N/A
Price to Earnings (P/E): ―
Beta: 0.08
Next Earnings: N/A
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

CLEO Diagnostics Ltd News

Cleo Diagnostics Advances FDA Pathway and Ovarian Cancer Screening Program

CLEO Diagnostics Ltd ( ($AU:COV) ) has shared an update. Cleo Diagnostics has moved from assay development into formal regulatory validation after receiving the first commercial batch of test kits

2d agoCOV

Cleo Diagnostics’ Ovarian Cancer Screen Clears First Proof-of-Concept Hurdle

CLEO Diagnostics Ltd ( ($AU:COV) ) has provided an update. Cleo Diagnostics has reported that its prototype ovarian cancer screening test met or exceeded all predefined performance targets in a

1w agoCOV

Cleo Diagnostics Starts Key Validation Phase for Ovarian Cancer Test Ahead of FDA Bid

The latest update is out from CLEO Diagnostics Ltd ( ($AU:COV) ). Cleo Diagnostics has begun Analytical Validation of its pre-surgical ovarian cancer test, marking the first formal regulatory study

2w agoCOV

Cleo Diagnostics strengthens IP for ovarian cancer screening platform

The latest update is out from CLEO Diagnostics Ltd ( ($AU:COV) ). Cleo Diagnostics has filed two new provisional patent applications to secure intellectual property surrounding biomarker combinations used in

1M agoCOV

Cleo Diagnostics Launches Development of Ovarian Cancer Screening Blood Test

CLEO Diagnostics Ltd ( ($AU:COV) ) has issued an update. Cleo Diagnostics has begun prototype development of a multi-marker blood screening test for early-stage ovarian cancer in asymptomatic women, marking

1M agoCOV

Cleo Diagnostics Sets Date and Digital Access for 2026 AGM

The latest update is out from CLEO Diagnostics Ltd ( ($AU:COV) ). Cleo Diagnostics Ltd has scheduled its 2026 Annual General Meeting for 26 November 2026 at 10.00am AEDT in

1M agoCOV

Cleo Diagnostics Calls 2026 AGM to Review Governance and Re-Elect Director

CLEO Diagnostics Ltd ( ($AU:COV) ) has issued an announcement. Cleo Diagnostics Ltd has called its Annual General Meeting for 10.00am AEDT on Thursday, 26 November 2026, at Level 27,

1M agoCOV

Cleo Diagnostics Sets Date for 2026 AGM and Director Nomination Deadline

CLEO Diagnostics Ltd ( ($AU:COV) ) just unveiled an update. Cleo Diagnostics has scheduled its 2026 Annual General Meeting of shareholders for 26 November 2026 at 10:00am AEDT in Melbourne,

1M agoCOV

Cleo Diagnostics Director Exercises 1.5 Million Options to Increase Shareholding

CLEO Diagnostics Ltd ( ($AU:COV) ) has issued an update. Cleo Diagnostics Ltd has reported a change in director Lucinda Joan Frawley’s relevant interests, as disclosed to the ASX under

2M agoCOV

Cleo Diagnostics Issues New Shares Under Regulatory Exemption

CLEO Diagnostics Ltd ( ($AU:COV) ) has issued an announcement. Cleo Diagnostics Ltd has issued 5,271,661 fully paid ordinary shares, expanding its capital base without providing a disclosure document to

2M agoCOV

COV FAQ

What was CLEO Diagnostics Ltd’s price range in the past 12 months?

CLEO Diagnostics Ltd lowest share price was AU$0.27 and its highest was AU$0.90 in the past 12 months.

What is CLEO Diagnostics Ltd’s market cap?

CLEO Diagnostics Ltd’s market cap is AU$42.00M.

When is CLEO Diagnostics Ltd’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were CLEO Diagnostics Ltd’s earnings last quarter?

CLEO Diagnostics Ltd released its earnings results on Sep 02, 2026. The company reported -AU$0.029 earnings per share for the quarter.

Is CLEO Diagnostics Ltd overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does CLEO Diagnostics Ltd pay dividends?

CLEO Diagnostics Ltd does not currently pay dividends.

What is CLEO Diagnostics Ltd’s EPS estimate?

CLEO Diagnostics Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does CLEO Diagnostics Ltd have?

CLEO Diagnostics Ltd has 142,383,740 shares outstanding.

What happened to CLEO Diagnostics Ltd’s price movement after its last earnings report?

CLEO Diagnostics Ltd reported an EPS of -AU$0.029 in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of CLEO Diagnostics Ltd?

Currently, no hedge funds are holding shares in AU:COV

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

CLEO Diagnostics Ltd Stock Smart Score

Underperform

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description